Aerovance Obtains $38,000,000 Series C Financing Round

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    2929 7th Street Berkeley, CA 94710
  • Company Description
    Aerovance is a privately held biopharmaceutical company exclusively focused on developing and commercializing biotherapeutics.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
    Series C
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor

By posting a comment, you agree to our terms and conditions.